• 3428 Citations
  • 22 h-Index
1984 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Steven P Sparagana is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Tuberous Sclerosis Medicine & Life Sciences
Angiomyolipoma Medicine & Life Sciences
Astrocytoma Medicine & Life Sciences
Epilepsy Medicine & Life Sciences
Intraoperative Neurophysiological Monitoring Medicine & Life Sciences
Intraoperative Monitoring Medicine & Life Sciences
Kidney Medicine & Life Sciences
Bioelectric potentials Engineering & Materials Science

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1984 2019

  • 3428 Citations
  • 22 h-Index
  • 48 Article
  • 4 Conference contribution
  • 2 Chapter
  • 1 Editorial
1 Citation (Scopus)
Open Access
Cannabidiol
Epilepsy
Pharmacokinetics
Pediatrics
Pharmaceutical Preparations
5 Citations (Scopus)

Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: Final 4-year results from the randomized EXIST-1 and EXIST-2 studies

Franz, D. N., Budde, K., Kingswood, J. C., Belousova, E., Sparagana, S., de Vries, P. J., Berkowitz, N., Ridolfi, A. & Bissler, J. J., Jan 1 2018, (Accepted/In press) In : Journal of the European Academy of Dermatology and Venereology.

Research output: Contribution to journalArticle

Angiomyolipoma
Tuberous Sclerosis
Astrocytoma
Kidney
Skin
11 Citations (Scopus)

Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex the TREATMENT randomized clinical trial

TREATMENT Trial Collaborators, Jul 1 2018, In : JAMA Dermatology. 154, 7, p. 773-780 8 p.

Research output: Contribution to journalArticle

Angiofibroma
Tuberous Sclerosis
Sirolimus
Randomized Controlled Trials
Safety

Epilepsy treatment patterns among patients with tuberous sclerosis complex

Song, J., Swallow, E., Said, Q., Peeples, M., Meiselbach, M., Signorovitch, J., Kohrman, M., Korf, B., Krueger, D., Wong, M. & Sparagana, S., Aug 15 2018, In : Journal of the Neurological Sciences. 391, p. 104-108 5 p.

Research output: Contribution to journalArticle

Tuberous Sclerosis
Epilepsy
Pharmaceutical Preparations
Therapeutics
Databases
7 Citations (Scopus)

Biallelic mutations in the ferredoxin reductase gene cause novel mitochondriopathy with optic atrophy

Peng, Y., Shinde, D. N., Valencia, C. A., Mo, J. S., Rosenfeld, J., Cho, M. T., Chamberlin, A., Li, Z., Liu, J., Gui, B., Brockhage, R., Basinger, A., Alvarez-Leon, B., Heydemann, P., Magoulas, P. L., Lewis, A. M., Scaglia, F., Gril, S., Chong, S. C., Bower, M. & 22 others, Monaghan, K. G., Willaert, R., Plona, M. R., Dineen, R., Milan, F., Hoganson, G., Powis, Z., Helbig, K. L., Keller-Ramey, J., Harris, B., Anderson, L. C., Green, T., Sukoff Rizzo, S. J., Kaylor, J., Chen, J., Guan, M. X., Sellars, E., Sparagana, S. P., Gibson, J. B., Reinholdt, L. G., Tang, S. & Huang, T., Dec 1 2017, In : Human Molecular Genetics. 26, 24, p. 4937-4950 14 p.

Research output: Contribution to journalArticle

Optic Atrophy
Ferredoxins
Oxidoreductases
Mutation
Iron